Seattle-Based DexCare Acquired AI Startup Mila Health
The acquisition expands DexCare's automated patient scheduling and engagement capabilities.
Updated on Sept. 21, 2026 in Healthcare
Live Poll
Do you trust AI agents to manage your medical appointments and scheduling?
Seattle-based digital health firm DexCare has acquired Mila Health to integrate AI-driven communication agents into its patient access platform. The deal combines DexCare's existing nationwide network of 57 million patients with Mila Health's specialized AI messaging technology.
Why it matters
Healthcare providers are increasingly turning to automated AI agents to manage staffing shortages and patient scheduling, shifting the operational burden away from manual administrative calls. This consolidation allows health systems to deploy more sophisticated text and voice scheduling tools through a single vendor.
DexCare, which supports 57 million patients across its network, has secured $146 million in total capital since spinning out of Providence. The company now integrates the 25 employees from Mila Health into its existing 133-person workforce.
The players
DexCare
A Seattle-based digital health company that provides enterprise-level software for managing patient access, referrals, and scheduling.
Mila Health
An AI-focused startup that specializes in automated medical appointment scheduling and patient outreach tools.
Providence
A major non-profit healthcare system that acted as the institutional parent for DexCare's original spinout.
The details
DexCare manages complex healthcare operations including patient referrals and scheduling, which are now being augmented by Mila Health's AI agents. These agents handle automated outbound calls and texts to secure medical appointments for patients. By folding these AI capabilities into its platform, DexCare aims to provide health systems with a configurable tool to replace labor-intensive administrative tasks.
Timeline
DexCare acquired Womp in 2022.
DexCare raised $75 million in funding in 2023.
Mila Health launched in January 2024.
DexCare announced the acquisition of Mila Health on September 21, 2026.
Market Landscape
This move reflects a broader industry trend where healthcare platform providers are aggressively acquiring AI specialists to automate patient scheduling. The strategy follows a pattern set by DexCare's 2022 acquisition of Womp, highlighting a preference for internalizing communication tech.
Operators of health systems should monitor how AI-driven scheduling integrates into current insurance and referral protocols to determine if it reduces administrative overhead. Evaluate existing vendors for similar automation capacity to avoid falling behind on patient engagement metrics.
The takeaway
The move underscores the growing competitive necessity for health platforms to control the full stack of patient engagement tools. Operators should audit their current scheduling costs against the efficiency gains reported by peers using AI-based patient communication agents.
Further reading
For additional context on local industry shifts, visit the Healthcare section.
Live Poll
Do you trust AI agents to manage your medical appointments and scheduling?
